These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23806555)

  • 1. Development of stapled short helical peptides capable of inhibiting vitamin D receptor (VDR)-coactivator interactions.
    Demizu Y; Nagoya S; Shirakawa M; Kawamura M; Yamagata N; Sato Y; Doi M; Kurihara M
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4292-6. PubMed ID: 23806555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural development of stapled short helical peptides as vitamin D receptor (VDR)-coactivator interaction inhibitors.
    Misawa T; Demizu Y; Kawamura M; Yamagata N; Kurihara M
    Bioorg Med Chem; 2015 Mar; 23(5):1055-61. PubMed ID: 25637122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivators.
    Mita Y; Dodo K; Noguchi-Yachide T; Miyachi H; Makishima M; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1712-7. PubMed ID: 20144545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of benzodiazepine derivatives as LXXLL peptide mimetics that inhibit the interaction of vitamin D receptor with coactivators.
    Mita Y; Dodo K; Noguchi-Yachide T; Hashimoto Y; Ishikawa M
    Bioorg Med Chem; 2013 Feb; 21(4):993-1005. PubMed ID: 23294828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.
    Nandhikonda P; Lynt WZ; McCallum MM; Ara T; Baranowski AM; Yuan NY; Pearson D; Bikle DD; Guy RK; Arnold LA
    J Med Chem; 2012 May; 55(10):4640-51. PubMed ID: 22563729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRC2-3 binds to vitamin D receptor with high sensitivity and strong affinity.
    Egawa D; Itoh T; Kato A; Kataoka S; Anami Y; Yamamoto K
    Bioorg Med Chem; 2017 Jan; 25(2):568-574. PubMed ID: 27890450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural development of stabilized helical peptides as inhibitors of estrogen receptor (ER)-mediated transcription.
    Demizu Y; Misawa T; Nagakubo T; Kanda Y; Okuhira K; Sekino Y; Naito M; Kurihara M
    Bioorg Med Chem; 2015 Aug; 23(15):4132-4138. PubMed ID: 26183544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput system for analyzing ligand-induced cofactor recruitment by vitamin D receptor.
    Arai MA; Takeyama K; Ito S; Kato S; Chen TC; Kittaka A
    Bioconjug Chem; 2007; 18(3):614-20. PubMed ID: 17408240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
    Issa LL; Leong GM; Sutherland RL; Eisman JA
    J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative binding sites at the vitamin D receptor and their ligands.
    Mutchie TR; Yu OB; Di Milo ES; Arnold LA
    Mol Cell Endocrinol; 2019 Apr; 485():1-8. PubMed ID: 30654005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
    Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
    J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
    Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
    Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antagonist for the vitamin D receptor: vitamin D analogues with simple side chain structure.
    Sakamaki Y; Inaba Y; Yoshimoto N; Yamamoto K
    J Med Chem; 2010 Aug; 53(15):5813-26. PubMed ID: 20608741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge mapping in 3(10)-helical peptide chains by oxidation of the terminal ferrocenyl group.
    Donoli A; Marcuzzo V; Moretto A; Toniolo C; Cardena R; Bisello A; Santi S
    Org Lett; 2011 Mar; 13(6):1282-5. PubMed ID: 21341757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short Aib/Ala-based peptide helix is as stable as an Ala-based peptide helix double its length.
    Banerjee R; Basu G
    Chembiochem; 2002 Dec; 3(12):1263-6. PubMed ID: 12465037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.